Caitong International Asset Management’s Blueprint Medicines BPMC Stock Holding History

Caitong International Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-180	Closed	-$23.1K	–	1974
2025 Q2	$23.1K	Buy	+180	New	+$18.7K	0.02%	469
2025 Q1	–	Sell	-192	Closed	-$16.7K	–	2188
2024 Q4	$16.7K	Buy	+192	New	+$17.6K	0.02%	845

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caitong International Asset Management's BPMC Position: Q3 2025 in Review

Caitong International Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 180 shares — an estimated $23.1K sold.

Caitong International Asset Management first reported a position in BPMC in Q4 2024 and held it in 2 quarters. The position peaked at $23.1K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Caitong International Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Caitong International Asset Management sold 180 Blueprint Medicines shares in Q3 2025, an estimated $23.1K.
Caitong International Asset Management first reported a position in Blueprint Medicines in Q4 2024 and held it in 2 quarters.
Caitong International Asset Management's Blueprint Medicines position peaked at $23.1K in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.